Related references
Note: Only part of the references are listed.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Use of Antimalarial Drugs against Viral Infection
Sarah D'Alessandro et al.
MICROORGANISMS (2020)
Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome
Marie-Helene Odievre et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
J. -M. Michot et al.
ANNALS OF ONCOLOGY (2020)
Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
Suxin Wan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome A Cautionary Case Report
Jared Radbel et al.
CHEST (2020)
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
Kui Liu et al.
CHINESE MEDICAL JOURNAL (2020)
Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19
Yabo Ouyang et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Zhongliang Wang et al.
CLINICAL INFECTIOUS DISEASES (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
Mingkai Tan et al.
IMMUNOLOGY (2020)
Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib
Jeffrey Jacobs et al.
INFLAMMATORY BOWEL DISEASES (2020)
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Xiaochen Li et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
Zhenwei Yang et al.
JOURNAL OF INFECTION (2020)
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China
Bo XU et al.
JOURNAL OF INFECTION (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence
Jeanne Lenzer
BMJ-BRITISH MEDICAL JOURNAL (2020)
Kidney disease is associated with in-hospital death of patients with COVID-19
Yichun Cheng et al.
KIDNEY INTERNATIONAL (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)
Lei Zha et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease
Antoney J. Ferrey et al.
AMERICAN JOURNAL OF NEPHROLOGY (2020)
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
Xuhan Zhang et al.
BLOOD ADVANCES (2020)
Checkpoint inhibitor therapy in preclinical sepsis models: a systematic review and meta-analysis
Lindsay M. Busch et al.
INTENSIVE CARE MEDICINE EXPERIMENTAL (2020)
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
Wei Zhou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
Yong Xiong et al.
EMERGING MICROBES & INFECTIONS (2020)
Hemozoin-induced activation of human monocytes toward M2-like phenotype is partially reversed by antimalarial drugs-chloroquine and artemisinin
Deepali Bobade et al.
MICROBIOLOGYOPEN (2019)
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)
Richard S. Hotchkiss et al.
CRITICAL CARE MEDICINE (2019)
Decoding the enigma of antiviral crisis: Does one target molecule regulate all?
Abdullah Mahmud-Al-Rafat et al.
CYTOKINE (2019)
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
Richard S. Hotchkiss et al.
INTENSIVE CARE MEDICINE (2019)
Dihydroartemisinin attenuates lipopolysaccharide-induced acute lung injury in mice by suppressing NF-κB signaling in an Nrf2-dependent manner
Xiao-Ting Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
Weiting Qin et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression
Zuowang Cheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Artesunate Attenuates Pro-Inflammatory Cytokine Release from Macrophages by Inhibiting TLR4-Mediated Autophagic Activation via the TRAF6-Beclinl-PI3KC3 Pathway
Mei Kuang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease
Zhongfang Wang et al.
NATURE COMMUNICATIONS (2018)
Rheumatoid arthritis
Josef S. Smolen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Plasmodium falciparum Treated with Artemisinin-based Combined Therapy Exhibits Enhanced Mutation, Heightened Cortisol and TNF-α Induction
Abel Olusola Idowu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Dihydroartemisinin derivative DC32 attenuates collagen-induced arthritis in mice by restoring the Treg/Th17 balance and inhibiting synovitis through down-regulation of IL-6
Menglin Fan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria
Yunting Du et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy
Hiroshi Nakanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
IL-10: A Multifunctional Cytokine in Viral Infections
Jose M. Rojas et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Artesunate Protects Against Sepsis-Induced Lung Injury Via Heme Oxygenase-1 Modulation
Tian-hui Cao et al.
INFLAMMATION (2016)
Artemisinin protects mice against burn sepsis through inhibiting NLRP3 inflammasome activation
Huibao Long et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2016)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Artesunate ameliorates severe acute pancreatitis (SAP) in rats by inhibiting expression of pro-inflammatory cytokines and Toll-like receptor 4
Yanyan Cen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells
Janne Tynell et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Immune suppressive properties of artemisinin family drugs
Lifei Hou et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study
Rui Shao et al.
CRITICAL CARE (2016)
First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report
Frank Bruenger et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2015)
Anti-Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives
Chenchen Shi et al.
MEDIATORS OF INFLAMMATION (2015)
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
Allison L. Totura et al.
MBIO (2015)
Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
Yaseen M. Arabi et al.
ANNALS OF INTERNAL MEDICINE (2014)
Mechanism of NLRP3 inflammasome activation
Fayyaz S. Sutterwala et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus
R. Germi et al.
ANTIVIRAL RESEARCH (2014)
Middle East Respiratory Syndrome Coronavirus: A Case-Control Study of Hospitalized Patients
Jaffar A. Al-Tawfiq et al.
CLINICAL INFECTIOUS DISEASES (2014)
Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice
Xueqin Huang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
Jie Zhou et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses
Vineet D. Menachery et al.
MBIO (2014)
IL-6 in Inflammation, Immunity, and Disease
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Hyperimmune IV Immunoglobulin Treatment of 2009 Influenza A(H1N1) Response
Ivan F. N. Hung et al.
CHEST (2013)
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
Susanna K. P. Lau et al.
JOURNAL OF GENERAL VIROLOGY (2013)
P2X7R: A potential key regulator of acute gouty arthritis
Jin-Hui Tao et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Inessa Schwab et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Marissa M. Alejandria et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Newly described pattern recognition receptors team up against intracellular pathogens
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Hydroxychloroquine: From Malaria to Autoimmunity
Ilan Ben-Zvi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Artemisinin inhibits lipopolysaccharide-induced interferon-β production in RAW 264.7 cells: Implications on signal transducer and activator of transcription-1 signaling and nitric oxide production
Ki Hwan Park et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung
O. Dienz et al.
MUCOSAL IMMUNOLOGY (2012)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Oral Administration of Artemisinin Analog SM934 Ameliorates Lupus Syndromes in MRL/lpr Mice by Inhibiting Th1 and Th17 Cell Responses
Li-Fei Hou et al.
ARTHRITIS AND RHEUMATISM (2011)
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
Taro Kawai et al.
IMMUNITY (2011)
Phenotypical and functional specialization of FOXP3+ regulatory T cells
Daniel J. Campbell et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Clinical review: Blood purification for sepsis
Thomas Rimmele et al.
CRITICAL CARE (2011)
Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-α release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-κB activation
Bin Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-κB pathways in RAW 264.7 macrophages
Jun-xia Wang et al.
ACTA PHARMACOLOGICA SINICA (2009)
Cytokine Responses in a Severe Case of Glandular Fever Treated Successfully with Foscarnet Combined with Prednisolone and Intravenous Immunoglobulin
Christine Ma et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses
J-X Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation
Michael Y. Shapira et al.
CLINICAL INFECTIOUS DISEASES (2008)
Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation
J-X Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Mark J. Cameron et al.
JOURNAL OF VIROLOGY (2007)
Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappa B and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes
H. Xu et al.
RHEUMATOLOGY (2007)
Treatment of severe acute respiratory syndrome with glucosteroids - The Guangzhou experience
Rong-chang Chen et al.
CHEST (2006)
Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro
YT Yen et al.
JOURNAL OF VIROLOGY (2006)
The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients
Chung-Hua Hsu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2006)
Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells
HKW Law et al.
BLOOD (2005)
Multiple organ infection and the pathogenesis of SARS
J Gu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Severe acute respiratory syndrome and the innate immune responses: Modulation of effector cell function without productive infection
CTK Tseng et al.
JOURNAL OF IMMUNOLOGY (2005)
Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis
CY Cheung et al.
JOURNAL OF VIROLOGY (2005)
The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: A prospective cohort study
JTF Lau et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2005)
An interferon-γ-related cytokine storm in SARS patients
KJ Huang et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Using herbal medicine as a means of prevention experience during the SARS crisis
TF Lau et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2005)
Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome
TS Li et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
Negative regulation of nuclear factor-κB activation and function by glucocorticoids
WY Almawi et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2002)
Share Paper
